{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:32:25Z","timestamp":1792459945875,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,1,21]],"date-time":"2013-01-21T00:00:00Z","timestamp":1358726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,1,21]],"date-time":"2013-01-21T00:00:00Z","timestamp":1358726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1038\/bmt.2012.264","type":"journal-article","created":{"date-parts":[[2013,1,21]],"date-time":"2013-01-21T12:04:52Z","timestamp":1358769892000},"page":"953-957","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Major ABO-incompatible BMT: isohemagglutinin reduction with plasma exchange is safe and avoids graft manipulation"],"prefix":"10.1038","volume":"48","author":[{"given":"D","family":"Sheppard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"McDiarmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Huebsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Tokessy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Hamelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Saidenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Bredeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,21]]},"reference":[{"key":"BFbmt2012264_CR1","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.3324\/haematol.2008.001057","volume":"93","author":"N Worel","year":"2008","unstructured":"Worel N, Kalhs P . AB0-incompatible allogeneic hematopoietic stem cell transplantation. Haematologica 2008; 93: 1605\u20131607.","journal-title":"Haematologica"},{"key":"BFbmt2012264_CR2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/sj.bmt.1703135","volume":"28","author":"SD Rowley","year":"2001","unstructured":"Rowley SD . Hematopoietic stem cell transplantation between red cell incompatible donor-recipient pairs. Bone Marrow Transplant 2001; 28: 315\u2013321.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012264_CR3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1182\/blood.V75.1.290.290","volume":"75","author":"J Gmur","year":"1990","unstructured":"Gmur J, Burger J, Schaffner A, Neftel K, Oelz O, Frey D et al. Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation [see comments]. Blood 1990; 75: 290\u2013295.","journal-title":"Blood"},{"key":"BFbmt2012264_CR4","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/j.1365-2141.2005.05364.x","volume":"128","author":"LM Griffith","year":"2005","unstructured":"Griffith LM, McCoy JP, Bolan CD, Stroncek DF, Pickett AC, Linton GF et al. Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation. Br J Haematol 2005; 128: 668\u2013675.","journal-title":"Br J Haematol"},{"key":"BFbmt2012264_CR5","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.3324\/haematol.12933","volume":"93","author":"F Kimura","year":"2008","unstructured":"Kimura F, Sato K, Kobayashi S, Ikeda T, Sao H, Okamoto S et al. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program. Haematologica 2008; 93: 1686\u20131693.","journal-title":"Haematologica"},{"key":"BFbmt2012264_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/sj.bmt.1703621","volume":"30","author":"GMJ Stussi","year":"2002","unstructured":"Stussi GMJ, Passeg JR, Seebach L, Schanz U, Gmur J, Gratwohl A et al. Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 30: 87\u201393.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012264_CR7","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.bbmt.2010.03.021","volume":"16","author":"N Blin","year":"2010","unstructured":"Blin N, Traineau R, Houssin S, Peffault de Latour R, Petropoulou A, Robin M et al. Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant 2010; 16: 1315\u20131323.","journal-title":"Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant"},{"key":"BFbmt2012264_CR8","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.bbmt.2007.01.084","volume":"13","author":"M Remberger","year":"2007","unstructured":"Remberger M, Watz E, Ringd\u00e9n O, Mattsson J, Shanwell A, Wikman A . Major ABO blood group mismatch increases the risk for graft failure after unrelated donor hematopoietic stem cell transplantation. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant 2007; 13: 675\u2013682.","journal-title":"Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant"},{"key":"BFbmt2012264_CR9","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.bbmt.2008.01.003","volume":"14","author":"IB Resnick","year":"2008","unstructured":"Resnick IB, Tsirigotis PD, Shapira MY, Aker M, Bitan M, Samuel S et al. ABO incompatibility is associated with increased non-relapse and GVHD related mortality in patients with malignancies treated with a reduced intensity regimen: a single center experience of 221 patients. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant 2008; 14: 409\u2013417.","journal-title":"Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant"},{"key":"BFbmt2012264_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1046\/j.1537-2995.1999.39299154733.x","volume":"39","author":"RJ Benjamin","year":"1999","unstructured":"Benjamin RJ, McGurk S, Ralston MS, Churchill WH, Antin JH . ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation. Transfusion 1999; 39: 179\u2013187.","journal-title":"Transfusion"},{"key":"BFbmt2012264_CR11","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1111\/j.1537-2995.2004.04106.x","volume":"44","author":"C Canals","year":"2004","unstructured":"Canals C, Mu\u00f1iz-D\u00edaz E, Mart\u00ednez C, Martino R, Moreno I, Ramos A et al. Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning. Transfusion 2004; 44: 1603\u20131611.","journal-title":"Transfusion"},{"key":"BFbmt2012264_CR12","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.bbmt.2005.07.015","volume":"11","author":"JD Seebach","year":"2005","unstructured":"Seebach JD, Stussi G, Passweg JR, Loberiza FR, Gajewski JL, Keating A et al. ABO blood group barrier in allogeneic bone marrow transplantation revisited. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant 2005; 11: 1006\u20131013.","journal-title":"Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant"},{"key":"BFbmt2012264_CR13","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/j.1537-2995.2008.02043.x","volume":"49","author":"J Kanda","year":"2009","unstructured":"Kanda J, Ichinohe T, Matsuo K, Benjamin RJ, Klumpp TR, Rozman P et al. Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studies. Transfusion 2009; 49: 624\u2013635.","journal-title":"Transfusion"},{"key":"BFbmt2012264_CR14","volume-title":"Technical Manual of the American Association of Blood Banks","author":"JCM Roback","year":"2008","unstructured":"Roback JCM, Grossman B, Hillyer C (eds).. Technical Manual of the American Association of Blood Banks. American Association of Blood Banks: Bethesda, 2008."},{"key":"BFbmt2012264_CR15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1182\/blood.V50.2.185.185","volume":"50","author":"R Gale","year":"1977","unstructured":"Gale R, Feig S, Ho W, Falk P, Rippee C, Sparkes R . ABO blood group system and bone marrow transplantation. Blood 1977; 50: 185\u2013194.","journal-title":"Blood"},{"key":"BFbmt2012264_CR16","first-page":"59","volume":"35","author":"G Stussi","year":"2006","unstructured":"Stussi G, Halter J, Schanz U, Seebach JD . ABO-histo blood group incompatibility in hematopoietic stem cell and solid organ transplantation. Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Off J Eur Soc Haemapheresis 2006; 35: 59\u201369.","journal-title":"Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Off J Eur Soc Haemapheresis"},{"key":"BFbmt2012264_CR17","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/00007890-198204000-00017","volume":"33","author":"WIBC Bensinger","year":"1982","unstructured":"Bensinger WIBC, Thomas ED, Clift RA . ABO-incompatible marrow transplants. Transplantation 1982; 33: 427\u2013429.","journal-title":"Transplantation"},{"key":"BFbmt2012264_CR18","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/sj.bmt.1704579","volume":"34","author":"R Raimondi","year":"2004","unstructured":"Raimondi R, Soli M, Lamparelli T, Bacigalupo A, Arcese W, Belloni M et al. ABO-incompatible bone marrow transplantation: a GITMO survey of current practice in Italy and comparison with the literature. Bone Marrow Transplant 2004; 34: 321\u2013329.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012264_CR19","volume-title":"AABB Technical Manual","author":"M Brecher","year":"2005","unstructured":"Brecher M (ed).. AABB Technical Manual 15th edn. American Association of Blood Banks: Bethesda, MD, 2005."},{"key":"BFbmt2012264_CR20","volume-title":"Marrow and Stem Cell Processing for Transplantation","author":"LC Lasky","year":"1995","unstructured":"Lasky LC, WP (eds). Marrow and Stem Cell Processing for Transplantation. AABB: Bethesda, 1995."},{"key":"BFbmt2012264_CR21","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.bbmt.2009.01.017","volume":"15","author":"HM Lazarus","year":"2009","unstructured":"Lazarus HM, Kan F, Tarima S, Champlin RE, Confer DL, Frey N et al. Rapid transport and infusion of hematopoietic cells is associated with improved outcome after myeloablative therapy and unrelated donor transplant. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant 2009; 15: 589\u2013596.","journal-title":"Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant"},{"key":"BFbmt2012264_CR22","first-page":"793","volume":"16","author":"BVDB Bar","year":"1995","unstructured":"Bar BVDB, Schattenberg A, de Man AJ, Kunst V, de Witte T . Erythrocyte repopulation after major ABO incompatible transplantation with lymphocyte-depleted bone marrow. Bone Marrow Transplant 1995; 16: 793\u2013799.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012264_CR23","first-page":"4623","volume":"18","author":"JSC Reviron","year":"1987","unstructured":"Reviron JSC, Bussel A, Devergie A, Gluckman E . Evidence for different kinds of major ABO incompatibility in transplantation due to the interplay of qualitative and quantitative factors: application to the management of 62 bone marrow recipients. Transplant Proc 1987; 18: 4623\u20134628.","journal-title":"Transplant Proc"},{"key":"BFbmt2012264_CR24","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1182\/blood.V60.2.420.420","volume":"60","author":"H Braine","year":"1982","unstructured":"Braine H, Sensenbrenner L, Wright S, Tutschka P, Saral R, Santos G . Bone marrow transplantation with major ABO blood group incompatibility using erythrocyte depletion of marrow prior to infusion. Blood 1982; 60: 420\u2013425.","journal-title":"Blood"},{"key":"BFbmt2012264_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3324\/haematol.13356","volume":"94","author":"G Stussi","year":"2009","unstructured":"Stussi G, Halter J, Bucheli E, Valli PV, Seebach L, Gm\u00fcr J et al. Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins. Haematologica 2009; 94: 239\u2013248.","journal-title":"Haematologica"},{"key":"BFbmt2012264_CR26","volume-title":"ASH Annual Meeting and Exposition","author":"C Anasetti","year":"2011","unstructured":"Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR et al. Increased incidence of chronic graft-versus-host disease (GVHD) and no survival advantage with filgrastim-mobilized peripheral blood stem cells (PBSC) compared to bone marrow (BM) transplants from unrelated donors: results of blood and marrow transplant clinical trials network (BMT CTN) protocol 0201, a phase III, prospective, randomized trial. ASH Annual Meeting and Exposition. San Diego, California, USA, 2011."}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2012264.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2012264","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2012264.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T16:12:10Z","timestamp":1648051930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2012264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,21]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["BFbmt2012264"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2012.264","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,21]]},"assertion":[{"value":"15 March 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}